尿路感染症(Urinary Tract Infections)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Urinary Tract Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Urinary Tract Infections 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Urinary Tract Infections Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Urinary Tract Infections 34
Oct 06, 2014: Tetraphase Pharmaceuticals Announces Initiation of Pivotal Portion of IGNITE 2 Phase 3 Trial of Eravacycline in cUTI 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Merck & Co., Inc. 35
Clinical Trial Overview of Merck & Co., Inc. 35
Zambon Company S.p.A. 36
Clinical Trial Overview of Zambon Company S.p.A. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Astellas Pharma Inc. 40
Clinical Trial Overview of Astellas Pharma Inc. 40
Janssen Pharmaceuticals, Inc. 41
Clinical Trial Overview of Janssen Pharmaceuticals, Inc. 41
Daiichi Sankyo Company, Limited 42
Clinical Trial Overview of Daiichi Sankyo Company, Limited 42
Tetraphase Pharmaceuticals Inc. 43
Clinical Trial Overview of Tetraphase Pharmaceuticals Inc. 43
Actavis plc 44
Clinical Trial Overview of Actavis plc 44
Clinical Trial Overview of Top Institutes / Government 45
National Center for Complementary and Alternative Medicine 45
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 45
U.S. Department of Veterans Affairs 46
Clinical Trial Overview of U.S. Department of Veterans Affairs 46
Assistance Publique – Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 47
Lawson Health Research Institute 48
Clinical Trial Overview of Lawson Health Research Institute 48
University of Washington 49
Clinical Trial Overview of University of Washington 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Samsung Medical Center 51
Clinical Trial Overview of Samsung Medical Center 51
University of Pittsburgh 52
Clinical Trial Overview of University of Pittsburgh 52
Leiden University Medical Center 53
Clinical Trial Overview of Leiden University Medical Center 53
University of Missouri 54
Clinical Trial Overview of University of Missouri 54
Five Key Clinical Profiles 55
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81